News Headlines Article

UC San Diego Study: Chantix Doesn’t Significantly Help Smokers Quit

The latest research from UC San Diego shows the popular smoking cessation drug, Chantix, has no significant impact on the rate in which Americans stop smoking.

According to research published online in Tobacco Control this week, the effectiveness of the drug is short-lived in comparison to other cessation aides. Researchers found the drug’s effectiveness lasts for three months. After this time, users report they no longer had a higher rate of success with the drug.